Spectracef (cefditoren pivoxil), a new third generation cephalosporin

October 2001

You'll soon see Spectracef (cefditoren pivoxil), a new third generation cephalosporin from TAP pharmaceuticals.

It's approved for patients 12 and older for bronchitis...pharyngitis...tonsillitis...and uncomplicated skin infections.

Spectracef is a "me-too"...comparable to Ceftin (cefuroxime) or Duricef (cefadroxil).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote